April 29th 2024
The CDMO’s boost in production will be centered around pharmaceutical products.
Sanofi, AstraZeneca Launch Program to Mitigate Future RSV Vaccine Shortages
February 2nd 2024New reservation program for Beyfortus (nirsevimab-alip) seeks to improve access to the monoclonal antibody that is FDA-approved to protect against respiratory syncytial virus-associated lower respiratory tract disease.
In New Year, Resolve to Solve Drug Supply Chain Security Act Compliance
January 31st 2024Under the DSCSA law, wholesale distributors, re-packagers, dispensers, and other third-party logistics providers must implement interoperable and electronic tracing of prescription products at the package level.